MoneyWorks4Me

Bacil Pharma - Quaterly Results

26 May 2025 Evaluate
A minor change in the total revenue was seen in the March 2025 quarter. The total revenue for the quarter stood at Rs. 0.00 millions against Rs. 0.00 millions during year ago period.The Total Profit for the quarter ended March 2025 of Rs. 0.16 millions grew from Rs.-0.42 millions Operating profit Margin for the quarter ended March 2025 improved to 0.16% as compared to -0.41% of corresponding quarter ended March 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Income 0.88 0.21 319.05 6.61 1.31 404.58 6.61 1.31 404.58
PBIDT 0.16 -0.41 -139.02 4.08 -0.57 -815.79 4.08 -0.57 -815.79
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 0.16 -0.41 -139.02 4.08 -0.57 -815.79 4.08 -0.57 -815.79
Depreciation 0.00 0.01 0.00 0.01 0.02 -50.00 0.01 0.02 -50.00
PBT 0.16 -0.42 -138.10 4.07 -0.59 -789.83 4.07 -0.59 -789.83
TAX 0.00 0.00 0.00 0.03 0.00 0.00 0.03 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.03 0.00 0.00 0.03 0.00 0.00
PAT 0.16 -0.42 -138.10 4.04 -0.59 -784.75 4.04 -0.59 -784.75
Equity 58.90 58.90 0.00 58.90 58.90 0.00 58.90 58.90 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..